Q: What is Syfovre used for?

Syfovre is used to treat geographic atrophy secondary to age-related macular degeneration .

Q: How does Syfovre work?

Targeting the Complement System Syfovre is a type of medication known as a complement inhibitor. The complement system is a group of proteins that are part of the body's natural immune response. While this system normally helps fight infections, it can sometimes become overactive and attack healthy tissue. How Pegcetacoplan Works In people with geographic atrophy (GA), which is an advanced form of age-related macular degeneration, the complement system is thought to be overactive. This overactivity leads to the destruction of cells in the retina, the part of the eye responsible for vision. Syfovre works by: Binding to a specific protein called complement component 3 (C3). Preventing C3 from breaking down into smaller fragments that trigger inflammation and cell death. Regulating the immune response to slow the growth of lesions (areas of tissue loss) in the retina. By controlling this immune pathway, the medication aims to preserve more of the retinal tissue over time. It is important to understand that while Syfovre is designed to slow the progression of the disease, it does not restore vision that has already been lost and is not a cure for geographic atrophy.

Q: What are the active ingredients in Syfovre?

The active ingredient in Syfovre is pegcetacoplan .

Q: What are the side effects of Syfovre?

Common side effects of Syfovre may include: eye pain floaters blurred vision Always consult with a healthcare professional about potential side effects.

Q: What drug class is Syfovre?

Syfovre belongs to the PD-1 inhibitor drug class.

Q: What is the dosage of Syfovre and how do I take it?

Administration Syfovre is given as an intravitreal injection, which means it is injected directly into the eye. This procedure is performed by a healthcare professional, such as an ophthalmologist, in a clinical setting. Before the injection, the healthcare provider will clean the eye to help prevent infection and apply a local anesthetic to numb the area. You may feel a sensation of pressure during the injection. Dosing Schedule The frequency of treatment is determined by a doctor. It is generally administered as a single injection into each affected eye once every 25 to 60 days. Missed Dose If an appointment for an injection is missed, it should be rescheduled as soon as possible. Your healthcare provider will then determine the timing for your next dose based on the recommended treatment interval.

Q: Is Syfovre safe during pregnancy and breastfeeding?

Pregnancy It is not known if Syfovre can cause harm to an unborn baby when administered to a pregnant person. There are no adequate or well-controlled studies of this medication in pregnant women. In animal studies involving monkeys, high doses of the drug were associated with an increased risk of pregnancy loss, although no structural malformations were observed in the offspring. Syfovre should only be used during pregnancy if the potential benefit to the patient outweighs the potential risk to the fetus. Breastfeeding It is unknown whether Syfovre passes into human breast milk, how it affects milk production, or if it has any effect on a breastfed infant. Because many drugs are excreted in human milk, caution is advised. Patients who are breastfeeding or planning to breastfeed should discuss the potential risks and benefits with their healthcare provider before starting treatment.

Q: What forms and strengths does Syfovre come in?

Dosage Forms Syfovre is supplied as a sterile, preservative-free solution for intravitreal injection. It is provided in a single-dose glass vial intended for use in one eye only. This medication is administered by a healthcare professional as an injection directly into the vitreous of the eye.

Q: What is the FDA approval status of Syfovre?

FDA Approval Status The U.S. Food and Drug Administration (FDA) approved Syfovre in February 2023. It was the first medication approved specifically for the treatment of geographic atrophy, an advanced form of age-related macular degeneration that causes progressive and permanent vision loss. Approved Indications Syfovre is indicated for the treatment of geographic atrophy secondary to age-related macular degeneration. It is administered by a healthcare professional as an intravitreal injection directly into the eye. Regulatory History and Safety Monitoring Since its initial approval, the FDA and the manufacturer have monitored post-marketing safety reports. While clinical trials established the drug's safety profile, real-world use has led to updates in safety information regarding rare but serious side effects. These include: Retinal vasculitis (inflammation of the blood vessels in the retina) Retinal vascular occlusion (blockage of the blood vessels in the retina) There are currently no Boxed Warnings or Risk Evaluation and Mitigation Strategies (REMS) required for Syfovre by the FDA.

Question 1

What is Syfovre?

Accepted Answer

Syfovre is a complement inhibitor designed to manage the progression of advanced age-related vision loss. It works by regulating the complement cascade, a part of the immune system that can become overactive and lead to the destruction of retinal cells.

By targeting the C3 protein, the medication aims to reduce the rate of tissue loss in the eye. This mechanism is intended to help preserve the structure of the retina and slow the decline of vision over time.

Question 2

What is Syfovre used for?

Accepted Answer

Syfovre is used to treat geographic atrophy secondary to age-related macular degeneration.

Question 3

How does Syfovre work?

Accepted Answer

Targeting the Complement System

Syfovre is a type of medication known as a complement inhibitor. The complement system is a group of proteins that are part of the body's natural immune response. While this system normally helps fight infections, it can sometimes become overactive and attack healthy tissue.

How Pegcetacoplan Works

In people with geographic atrophy (GA), which is an advanced form of age-related macular degeneration, the complement system is thought to be overactive. This overactivity leads to the destruction of cells in the retina, the part of the eye responsible for vision. Syfovre works by:

Binding to a specific protein called complement component 3 (C3).
Preventing C3 from breaking down into smaller fragments that trigger inflammation and cell death.
Regulating the immune response to slow the growth of lesions (areas of tissue loss) in the retina.

By controlling this immune pathway, the medication aims to preserve more of the retinal tissue over time. It is important to understand that while Syfovre is designed to slow the progression of the disease, it does not restore vision that has already been lost and is not a cure for geographic atrophy.

Question 4

What are the active ingredients in Syfovre?

Accepted Answer

The active ingredient in Syfovre is pegcetacoplan.

Question 5

What are the side effects of Syfovre?

Accepted Answer

Common side effects of Syfovre may include:

eye pain
floaters
blurred vision

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Syfovre?

Accepted Answer

Syfovre belongs to the PD-1 inhibitor drug class.

Question 7

What is the dosage of Syfovre and how do I take it?

Accepted Answer

Administration

Syfovre is given as an intravitreal injection, which means it is injected directly into the eye. This procedure is performed by a healthcare professional, such as an ophthalmologist, in a clinical setting.

Before the injection, the healthcare provider will clean the eye to help prevent infection and apply a local anesthetic to numb the area. You may feel a sensation of pressure during the injection.

Dosing Schedule

The frequency of treatment is determined by a doctor. It is generally administered as a single injection into each affected eye once every 25 to 60 days.

Missed Dose

If an appointment for an injection is missed, it should be rescheduled as soon as possible. Your healthcare provider will then determine the timing for your next dose based on the recommended treatment interval.

Question 8

Is Syfovre safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

It is not known if Syfovre can cause harm to an unborn baby when administered to a pregnant person. There are no adequate or well-controlled studies of this medication in pregnant women. In animal studies involving monkeys, high doses of the drug were associated with an increased risk of pregnancy loss, although no structural malformations were observed in the offspring. Syfovre should only be used during pregnancy if the potential benefit to the patient outweighs the potential risk to the fetus.

Breastfeeding

It is unknown whether Syfovre passes into human breast milk, how it affects milk production, or if it has any effect on a breastfed infant. Because many drugs are excreted in human milk, caution is advised. Patients who are breastfeeding or planning to breastfeed should discuss the potential risks and benefits with their healthcare provider before starting treatment.

Question 9

What forms and strengths does Syfovre come in?

Accepted Answer

Dosage Forms

Syfovre is supplied as a sterile, preservative-free solution for intravitreal injection. It is provided in a single-dose glass vial intended for use in one eye only.

This medication is administered by a healthcare professional as an injection directly into the vitreous of the eye.

Question 10

What is the FDA approval status of Syfovre?

Accepted Answer

FDA Approval Status

The U.S. Food and Drug Administration (FDA) approved Syfovre in February 2023. It was the first medication approved specifically for the treatment of geographic atrophy, an advanced form of age-related macular degeneration that causes progressive and permanent vision loss.

Approved Indications

Syfovre is indicated for the treatment of geographic atrophy secondary to age-related macular degeneration. It is administered by a healthcare professional as an intravitreal injection directly into the eye.

Regulatory History and Safety Monitoring

Since its initial approval, the FDA and the manufacturer have monitored post-marketing safety reports. While clinical trials established the drug's safety profile, real-world use has led to updates in safety information regarding rare but serious side effects. These include:

Retinal vasculitis (inflammation of the blood vessels in the retina)
Retinal vascular occlusion (blockage of the blood vessels in the retina)

There are currently no Boxed Warnings or Risk Evaluation and Mitigation Strategies (REMS) required for Syfovre by the FDA.

Question 11

What should I know about Syfovre and cost?

Accepted Answer

Insurance and Administration

Syfovre is a specialty medication that must be administered by a healthcare professional as an injection into the eye. Because it is given in a clinical setting rather than being picked up at a pharmacy, it is typically covered under medical insurance benefits. The total cost usually includes the price of the medication itself and the professional fees for the office visit and the injection procedure.

Factors Influencing Cost

The overall expense of treatment with Syfovre can vary based on several variables:

Injection Frequency: Syfovre is typically administered once every 25 to 60 days. A more frequent treatment schedule will increase the total annual cost.
Insurance Plan Details: Your out-of-pocket costs are determined by your specific insurance plan, including deductibles, co-pays, or co-insurance requirements for medical procedures.
Healthcare Setting: The cost of the administration procedure may vary depending on whether the treatment is performed in a private doctor's office or a hospital-based clinic.

Because Syfovre is a specialized treatment, patients are encouraged to contact their insurance provider or healthcare office to obtain a specific cost estimate based on their individual treatment plan.

Syfovre

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Syfovre

Hospitals.net Disclosure